Managing Brain Metastases in the 21st Century: Treatment Options and Case Discussions

ASTRO's 59th Annual Meeting
Date: September 27, 2017
Time: 1:30 pm - 3:00 pm
 
As patients with metastatic disease are enjoying improved survival, brain metastases are an increasing problem. Technologic advances as well as emerging evidence suggests that the indications for radiosurgery are increasing, and can be performed without threatening quality of life. Similarly frameless radiosurgery has made hypofractionation very feasible. Integrating surgery and systemic therapy into the management of brain metastases is also an important consideration. The session will review treatment options and available evidence, including whole brain radiation, with these other modalities, and use case based discussions to illustrate salient points regarding such options in clinical management, including difficult cases, such as salvage treatment.

Target Audience

This continuing medical education activity is designed to meet the interests of radiation oncologists, radiation oncology residents, radiation biologists, radiation physicists, dosimetrists, oncologists working in related specialties, radiation therapists, radiation oncology nurses, radiation oncology administrators, diagnostic radiologists and all other health professionals involved in the field of radiation oncology.

Learning Objectives

After this session, attendees should be able to:

  • Discuss treatment options for managing brain metastases.
  • Discuss the medical evidence related to various treatment options for brain metastases.
  • Explain the indications and contraindications for treatment options.
Course summary
Available credit: 
  • 1.50 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this Live activity for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.

Course opens: 
09/27/2017
Course expires: 
09/27/2017
Cost:
$0.00
Rating: 
0

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

Available Credit

  • 1.50 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this Live activity for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.

Accreditation Period

Course opens: 
09/27/2017
Course expires: 
09/27/2017

Price

Cost:
$0.00
Please login or register to take this course.